scholarly journals Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus–16/18 Vaccine in Four- to Six-year-old Girls

2019 ◽  
Vol 38 (10) ◽  
pp. 1061-1067 ◽  
Author(s):  
Lan Lin ◽  
Mercedes Macias Parra ◽  
Victor Y. Sierra ◽  
Albino Salas Cespedes ◽  
Maria Angelica Granados ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Human Papillomavirus 16

scholarly journals Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain

2008 ◽  
Vol 18 (6) ◽  
pp. 674-680 ◽  
Author(s):  
A. Gauthier ◽  
V. Martin-Escudero ◽  
L. Moore ◽  
N. Ferko ◽  
S. de Sanjose ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Cancer Vaccine ◽  
Clinical Impact ◽  
Human Papillomavirus 16 ◽  
Cervical Cancer Vaccine

scholarly journals Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer

Cancer ◽  
1994 ◽  
Vol 74 (8) ◽  
pp. 2307-2313 ◽  
Author(s):  
Katja N. Gaarenstroom ◽  
Gemma G. Kenter ◽  
J. Baptist Trimbos ◽  
Johannes M. G. Bonfrer ◽  
Catharina M. Korse ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Prognostic Significance ◽  
Serum Antibodies ◽  
Human Papillomavirus 16

scholarly journals 171 Human papillomavirus genotype and long-term clinical outcomes of vulvar malignancies

2020 ◽  
Author(s):  
H Tung ◽  
Y Tang ◽  
L Yang ◽  
H Huang ◽  
R Wu ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Clinical Outcomes
Sign in / Sign up

Export Citation Format

Share Document